VSEE HEALTH, INC. (VSEE): Nasdaq/NYSE listing notice — VSee Health receives Nasdaq delisting determination; trading suspended Aug 14

VSEE HEALTH, INC.

Nasdaq denied VSee's request to continue listing due to late Form 10-K and 10-Q filings.
Trading in VSEE common and VSEEW warrants suspended at open on August 14, 2025.
Company will request reconsideration; shares expected to trade on OTC Markets from Aug 14.
No assurance that appeal or reconsideration will succeed.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

VSEE HEALTH, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

December 31, 2024 (the “Form 10-K”) with the Securities and Exchange Commission (the “SEC”). As previously reported, on May 23, 2025, the Company received a notice (the “Second Notice” and, together with the First Notice, the “Notices”) from the Staff of Nasdaq that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Form 10-Q”) with the SEC. On August 5, 2025, the Company received a letter from the Staff stating that the Staff had determined to deny the Compan

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-075813

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.